Clinical Trials on Glucose Intolerance in Canada
Total 1398 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, South Africa, Romania, Brazil, China, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, Puerto Rico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Australia, Philippines, Mexico, Puerto Rico
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
Intarcia TherapeuticsTerminatedDiabetes Mellitus, Type 2United States, Canada
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Brazil, Puerto Rico, Canada, India, Denmark, Czech Republic
-
SanofiRecruitingType 1 Diabetes MellitusBelgium, Spain, Canada, United States, Poland, France, Sweden, Denmark, Germany, Italy, United Kingdom, Hungary
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Argentina, India, Australia, Spain, Taiwan, France, Canada, Hungary, Mexico, Croatia, Korea, Republic of, Poland, Greece, Belgium, Brazil, Italy, Czech Republic, Romania, Slovakia, Sweden
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Israel, Malaysia, Mexico, Philippines, Puerto Rico, Russian Federation, Sri Lanka, Thailand, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 1United States, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Slovakia, Canada, South Africa, Puerto Rico, Poland
-
Duke UniversityEli Lilly and Company; Boehringer IngelheimActive, not recruitingCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusCanada, United States, Italy, Poland, Puerto Rico
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Korea, Republic of, Australia, India, Canada, Japan, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Thailand, Korea, Republic of, United Kingdom, China, Germany, Israel, Mexico, Argentina, Brazil, Colombia, Puerto Rico, Russian Federation
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Canada, Sweden, Latvia, Finland, Greece, Romania, Czechia, Puerto Rico
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Czech Republic, Russian Federation, Ukraine
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Puerto Rico, United States, Romania, United Kingdom, Spain, Mexico, Austria, South Africa, Germany, Ukraine, India
-
Provention Bio, a Sanofi CompanyActive, not recruitingDiabetes Mellitus, Type 1United States, Belgium, Canada, Czechia, France, Germany, Poland, United Kingdom
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Korea, Republic of, Australia, New Zealand, Mexico, Brazil
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, United Kingdom, Mexico, Russian Federation, Japan, Canada, Italy, South Africa, Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Puerto Rico, Germany, Turkey, Canada, Bulgaria
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Spain, Hungary, Mexico, Argentina, Slovakia, Greece, South Africa, Australia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Acute Myocardial InfarctionCanada, Croatia, Czech Republic, Germany, Hungary, India, Israel, Lebanon, Poland, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Turkey, United Kingdom
-
SanofiCompletedType 2 Diabetes MellitusSpain, United States, Canada, Czech Republic, France, Germany, Poland, Romania, Russian Federation, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Germany, Spain, Taiwan, Hungary, Poland, Korea, Republic of, Austria, New Zealand, United Kingdom, Czechia, Puerto Rico
-
TheracosCompletedDiabetes Mellitus, Type 2United States, Japan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, Hungary, Spain, United States, Australia, Puerto Rico, Poland, Belgium, Denmark, Brazil, Mexico, Greece, Argentina, Taiwan, Sweden, Russian Federation
-
Hoffmann-La RocheCompletedDiabetesUnited States, Panama, Mexico, Canada, Estonia, Lithuania, Bulgaria, Romania, Latvia, Puerto Rico, United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Canada, El Salvador, Germany, Italy, Portugal, Russian Federation, Spain, Ukraine
-
PfizerCompletedDiabetes Mellitus, Type 1United States, Canada
-
Hoffmann-La RocheCompletedDiabetesUnited States, Panama, Mexico, Estonia, Bulgaria, Romania, Puerto Rico, Switzerland, United Kingdom
-
Eli Lilly and CompanyActive, not recruitingType 2 DiabetesUnited States, United Kingdom, Germany, Mexico, Romania, Argentina, Canada, Puerto Rico, Israel, Italy, Slovakia
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Korea, Republic of, Australia, New Zealand
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico
-
GlaxoSmithKlineCompletedMetabolic Syndrome XSpain, Argentina, Australia, Latvia, India, Mexico, Pakistan, Slovakia, Costa Rica, New Zealand, Romania, Russian Federation, Chile
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Greece, Japan, Bulgaria, Slovakia, Ukraine, Czechia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Puerto Rico, Slovakia, Canada, South Africa, United Kingdom, Czech Republic
-
PfizerTerminatedObesity | Diabetes MellitusUnited States, Hungary, Canada, Japan, Poland, Puerto Rico, Bulgaria, Czechia
-
Theravance BiopharmaTerminatedParkinson's Disease (PD) | MSA | Symptomatic Neurogenic Orthostatic Hypotension | Pure Autonomic Failure (PAF)United States, Spain, United Kingdom, Canada, France, Estonia, Australia, Israel, Denmark, Italy, Poland, New Zealand, Germany, Ukraine, Austria, Bulgaria, Portugal, Hungary, Russian Federation
-
Bristol-Myers SquibbCompletedMetabolics Diabetes NosUnited States, Spain, Argentina, Brazil, Germany, Mexico, Peru, Puerto Rico, Australia, Canada, Russian Federation, United Kingdom, France, Italy, Netherlands
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation, Romania, Poland, Czech Republic, Puerto Rico, Hungary
-
PhenomixTerminatedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, India
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Puerto Rico, United Kingdom, Ireland, Germany, Slovenia, Canada, France, Italy, Spain, Netherlands, Slovakia, Romania, Former Serbia and Montenegro
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, Spain, Taiwan, Belgium, United Kingdom, Germany, Canada, Australia, Finland, Netherlands, Poland, France, Denmark, Norway, Sweden, Austria, Czechia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, China, France, Germany, India, Korea, Republic of, Mexico, Slovakia, Slovenia, Taiwan, Turkey